A carregar...
A Phase Ib open label, randomized, safety study of SANGUINATE™ in patients with sickle cell anemia
BACKGROUND: Treatment of sickle cell anemia is a challenging task and despite the well understood genetic and biochemical pathway of sickle hemoglobin, current therapy continues to be limited to the symptomatic treatment of pain, supplemental oxygen, antibiotics, red blood cell transfusions and hydr...
Na minha lista:
| Publicado no: | Rev Bras Hematol Hemoter |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Sociedade Brasileira de Hematologia e Hemoterapia
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5339363/ https://ncbi.nlm.nih.gov/pubmed/28270341 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bjhh.2016.08.004 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|